These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6703686)

  • 21. Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes.
    Ruiz-Balaguer N; Nacher A; Casabo VG; Merino Sanjuan M
    Int J Pharm; 2002 Mar; 234(1-2):101-11. PubMed ID: 11839441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Investigation of adsorption, metabolism and excretion of cefuroxime axetil in volunteers of gastrectomized patients].
    Ishibiki K; Inoue S; Suzuki F; Okumura K; Takeda K; Toshimitsu Y
    Jpn J Antibiot; 1990 Feb; 43(2):337-44. PubMed ID: 2362355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Esters of cephalosporins. Part IV. Hydrolysis of 1-acetoxyethyl ester of cefuroxime in vitro and in vivo.
    Tejchman B; Jaromińska M; Horodecka M; Oszczapowicz I
    Acta Pol Pharm; 1995; 52(6):477-82. PubMed ID: 8960266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability of cefuroxime axetil formulations.
    Donn KH; James NC; Powell JR
    J Pharm Sci; 1994 Jun; 83(6):842-4. PubMed ID: 9120818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.
    James NC; Donn KH; Collins JJ; Davis IM; Lloyd TL; Hart RW; Powell JR
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1860-3. PubMed ID: 1952858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infections.
    Hebblethwaite EM; Brown GW; Cox DM
    Drugs Exp Clin Res; 1987; 13(2):91-4. PubMed ID: 3582135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical studies on cefuroxime axetil in acute mastitis].
    Nakamura T; Hashimoto I; Sawada Y; Mikami J
    Jpn J Antibiot; 1987 Feb; 40(2):340-8. PubMed ID: 3599383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of cefuroxime axetil suspension in infants and children.
    Powell DA; James NC; Ossi MJ; Nahata MC; Donn KH
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2042-5. PubMed ID: 1759825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
    Nix DE; Symonds WT; Hyatt JM; Wilton JH; Teal MA; Reidenberg P; Affrime MB
    Pharmacotherapy; 1997; 17(1):121-5. PubMed ID: 9017772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioequivalence evaluation of 2 brands of cefuroxime axetil 250 mg tablets in healthy human volunteers.
    Pistos C; Michalea S; Kalovidouris M; Kontopoulos G; Georgarakis M
    Int J Clin Pharmacol Ther; 2004 Jul; 42(7):367-72. PubMed ID: 15605688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative bioavailability of cefuroxime axetil suspension formulations administered with food in healthy subjects.
    Mendes GD; Borges A; de Cássia Val L; Patni AK; Reyar S; Monif T; Sereno D; Orellana AM; De Nucci G
    Arzneimittelforschung; 2010; 60(2):101-5. PubMed ID: 20329659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Esters of cephalosporins. Part II. Differences in the properties of various forms of the 1-acetoxyethyl ester of cefuroxime.
    Oszczapowicz I; Małafiej E; Szelachowska M; Horoszewicz-Małafiej A; Kuklewicz C; Sierańska E; Denys A; Niedworok J
    Acta Pol Pharm; 1995; 52(5):397-401. PubMed ID: 8960273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains.
    Thorpe EM; Schwebke JR; Hook EW; Rompalo A; McCormack WM; Mussari KL; Giguere GC; Collins JJ
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2775-80. PubMed ID: 9124839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of cefuroxime axetil and amoxycillin in the treatment of acute sinusitis in general practice.
    Brodie DP; Knight S; Cunningham K
    J Int Med Res; 1989; 17(6):547-51. PubMed ID: 2628131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
    Higuera F; Hidalgo H; Feris J; Giguere G; Collins JJ
    J Antimicrob Chemother; 1996 Mar; 37(3):555-64. PubMed ID: 9182112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the serum and tissue concentrations of cefuroxime from cefuroxime axetil and phenoxymethylpenicillin in patients undergoing tonsillectomy.
    Jetlund O; Thurmann-Nielsen E; Walstad RA
    Int J Clin Pharmacol Res; 1991; 11(1):1-6. PubMed ID: 1908443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic models for the saturable absorption of cefuroxime axetil and saturable elimination of cefuroxime.
    Ruiz-Carretero P; Merino-Sanjuán M; Nácher A; Casabó VG
    Eur J Pharm Sci; 2004 Feb; 21(2-3):217-23. PubMed ID: 14757493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefuroxime axetil versus ofloxacin for short-term therapy of acute uncomplicated lower urinary tract infections in women.
    Naber KG; Koch EM
    Infection; 1993; 21(1):34-9. PubMed ID: 8449579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group.
    Siegert R; Gehanno P; Nikolaidis P; Bagger-Sjöbäck D; Ibanez JM; Hampel B; Sommerauer B
    Respir Med; 2000 Apr; 94(4):337-44. PubMed ID: 10845431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Esters of cephalosporins. Part III. Separation and properties of the R and S isomers of the 1-acetoxyethyl ester of cefuroxime.
    Oszczapowicz I; Małafiej E; Horoszewicz-Małafiej A; Szelachowska M; Kuklewicz C; Sierańska E
    Acta Pol Pharm; 1995; 52(6):471-6. PubMed ID: 8960265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.